These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25840793)
1. Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity? Bedogni G; Grugni G; Tringali G; Marazzi N; Sartorio A J Endocrinol Invest; 2015 Sep; 38(9):957-61. PubMed ID: 25840793 [TBL] [Abstract][Full Text] [Related]
2. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Lloret-Linares C; Faucher P; Coupaye M; Alili R; Green A; Basdevant A; Clément K; Poitou C Int J Obes (Lond); 2013 Sep; 37(9):1198-203. PubMed ID: 23318724 [TBL] [Abstract][Full Text] [Related]
3. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. Bekx MT; Carrel AL; Shriver TC; Li Z; Allen DB J Pediatr; 2003 Sep; 143(3):372-6. PubMed ID: 14517523 [TBL] [Abstract][Full Text] [Related]
4. Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Theodoro MF; Talebizadeh Z; Butler MG Obesity (Silver Spring); 2006 Oct; 14(10):1685-90. PubMed ID: 17062796 [TBL] [Abstract][Full Text] [Related]
5. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464 [TBL] [Abstract][Full Text] [Related]
6. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome. Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398 [No Abstract] [Full Text] [Related]
7. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. Viardot A; Sze L; Purtell L; Sainsbury A; Loughnan G; Smith E; Herzog H; Steinbeck K; Campbell LV J Clin Endocrinol Metab; 2010 Jul; 95(7):3392-9. PubMed ID: 20444923 [TBL] [Abstract][Full Text] [Related]
8. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. Lacroix D; Moutel S; Coupaye M; Huvenne H; Faucher P; Pelloux V; Rouault C; Bastard JP; Cagnard N; Dubern B; Clément K; Poitou C J Clin Endocrinol Metab; 2015 Mar; 100(3):850-9. PubMed ID: 25478934 [TBL] [Abstract][Full Text] [Related]
9. Is non-alcoholic fatty liver disease less frequent among women with Prader-Willi syndrome? Bedogni G; Grugni G; Nobili V; Agosti F; Saezza A; Sartorio A Obes Facts; 2014; 7(1):71-6. PubMed ID: 24577228 [TBL] [Abstract][Full Text] [Related]
10. Update on body composition and bone density in children with Prader-Willi syndrome. Rubin DA; Cano-Sokoloff N; Castner DL; Judelson DA; Wright P; Duran A; Haqq AM Horm Res Paediatr; 2013; 79(5):271-6. PubMed ID: 23615452 [TBL] [Abstract][Full Text] [Related]
11. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883 [TBL] [Abstract][Full Text] [Related]
13. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Kennedy L; Bittel DC; Kibiryeva N; Kalra SP; Torto R; Butler MG Int J Obes (Lond); 2006 Feb; 30(2):382-7. PubMed ID: 16231029 [TBL] [Abstract][Full Text] [Related]
14. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173 [TBL] [Abstract][Full Text] [Related]
15. Assessment of fat-free mass from bioelectrical impedance analysis in men and women with Prader-Willi syndrome: cross-sectional study. Bedogni G; Grugni G; Tringali G; Tamini S; Marzullo P; Sartorio A Int J Food Sci Nutr; 2019 Aug; 70(5):645-649. PubMed ID: 30714438 [TBL] [Abstract][Full Text] [Related]
16. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Goldstone AP; Brynes AE; Thomas EL; Bell JD; Frost G; Holland A; Ghatei MA; Bloom SR Am J Clin Nutr; 2002 Mar; 75(3):468-75. PubMed ID: 11864851 [TBL] [Abstract][Full Text] [Related]
17. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome. Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M Endocr J; 2018 Nov; 65(11):1127-1137. PubMed ID: 30185718 [TBL] [Abstract][Full Text] [Related]
18. Assessment of fat-free mass from bioelectrical impedance analysis in obese women with Prader-Willi syndrome. Bedogni G; Grugni G; Tringali G; Agosti F; Sartorio A Ann Hum Biol; 2015; 42(6):538-42. PubMed ID: 25541275 [TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 levels in Prader-Willi syndrome: comparison with obese and non-obese subjects. Butler MG; Dasouki M; Bittel D; Hunter S; Naini A; DiMauro S Am J Med Genet A; 2003 Jun; 119A(2):168-71. PubMed ID: 12749057 [TBL] [Abstract][Full Text] [Related]
20. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. Orsso CE; Mackenzie M; Alberga AS; Sharma AM; Richer L; Rubin DA; Prado CM; Haqq AM Metabolism; 2017 Apr; 69():67-75. PubMed ID: 28285653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]